G Protein-Coupled Receptors: Undervalued Targets for Cancer Therapy


  • Ismail Ibrahim Al-Janabi Retired Academic, Epsom UK




G protein-coupled receptor, cancer, signalling pathways, signal transduction, cancer hallmarks, targeting receptors.


Despite the G protein-coupled receptors (GPCRs) being the largest family of signalling proteins at the surface of cells, their potential to be targeted in cancer therapy is still under-utilised. This review highlights the contribution of these receptors to the process of oncogenesis and points to some likely challenges that might be encountered in targeting them. GPCR-signalling pathways are often complex and can be tissue-specific. Cancer cells hijack these communication networks to their proliferative advantage. The role of selected GPCRs in the different hallmarks of cancer is examined to highlight the complexity of targeting these receptors for therapeutic benefit. Our increasing knowledge of the mechanisms governing the molecular functions of GPCRs may help to identify new targets to treat specific types of cancers.



Bassilansa Frederic, Nash Mark and Ludwig Marie-Gabrielle. Adhesion G protein-coupled receptors: opportunities for drug discovery, Nature Reviews, 2019; 18: 869-884.

Hill Stephen J. G-protein-coupled receptors: past, present and future. British Journal of Pharmacology, 2006; 147: S27–S37.

G protein-coupled receptors database @GPCRdb.org, last accessed March 2021.

Allen John A. and Roth Bryan L. Strategies to discover unexpected targets for drugs active at G protein-coupled receptors. Annu Rev.Pharmacol.Toxicol. 2011; 51: 117–144.

Wootten Denise, Christopoulos Arthur, Marti-Solano Maria, Babu M. Madan and Sexton Patrick M. Mechanisms of signalling and biased agonism in G protein-coupled receptors. Nature Reviews. 2018; 19: 638-653.

Venkatakrishnan A. J., Deupi Xavier, Lebon Guillaume, Tate Christopher G., Schertler Gebhard F. and Babu M. Madan. Molecular signatures of G-protein-coupled receptors. Nature. 2013; 494: 185-194.

Yang Dehua, Zhou Qingtong, Labkaros Viktorija, Qin Shanshan, Darbalaei Sanaz, Wu Yiran et al. G protein-coupled receptors: structure- and function-based drug discovery. Signal Transduction and Targeted Therapy. 2021; 6(7): 1-27.

Arang Nadia and Gutkind J. Silvio. G Protein-Coupled receptors and heterotrimeric G proteins as cancer drivers. FEBS Letters. 2020; 594: 4201–4232.

KroezeWesley K., Sheffler Douglas J. and Roth Bryan L. G-protein-coupled receptors at a glance. Journal of Cell Science. 2003; 116 (24): 4867-4869.

Pierce Kristen L., Premon Richard T. and Lefkowitz Robert J. Seven-transmembrane receptors. Nature Reviews, 2002; 3: 639-650.

Karnak Sadashiva S., Gogonea Camelia, Patil Supriya, Saad Yasser and Takezako Takanobu. Activation of G-protein-coupled receptors: a common molecular mechanism. TRENDS in Endocrinology and Metabolism. 2003; 14(9): 431-437.

Tang Xiao-long, Wang Ying, Li Da-li, Luo Jian and Liu Ming-Yao. Orphan G protein-coupled receptors (GPCRs): biological functions and potential drug targets. Acta Pharmacologica Sinica. 2012; 33: 363–371.

Oldham William M. and Hamm Heidi E. Heterotrimeric G protein activation by G protein-coupled receptors. Nature Reviews. 2008; 9: 60-71.

De Francesco Ernestina M., Sotgia Federica, Clarke Robert B., Lisanti Michael P. and Maggiolini Marcello. G protein-coupled receptors at the crossroad between physiologic and pathologic angiogenesis: old paradigms and emerging concepts. Int. J. Mol. Sci. 2017; 18: 1-27.

Fredriksson Robert, Lagerstrom Malin C., Lundin Lars-Gustav and Schioth Helgi B. The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints. Molecular Pharmacology. 2003; 63(6): 1256-1272.

Rosenbaum Daniel M., Rasmussen Søren G. F. and Brian K. Kobilka. The structure and function of G-protein-coupled receptors. Nature. 2009; 459: 356-363.

Neer Eva J. Heterotrimeric G proteins: Organizers of transmembrane signals. Cell. 1995; 80: 249-257.

Lefkowitz Robert J. A brief history of G protein-coupled receptors. Nobel lecture, December 8, 2012.

Cornwell Abigail C. and Feigin Michael E. Unintended effects of GPCR-targeted drugs on the cancer phenotype. Trends in Pharmacological Sciences. 2020; 4(12): 1006-1022.

Landis Claudia A., Masters Susan B., Spada Anna, Pace Ann M., Bourne Henry R. and Vallar Lucia. GTPase inhibiting mutations activate the alpha chain of Gs and stimulate adenylyl cyclase in human pituitary tumours. Nature. 1989; 340: 692-696.

Weis William I. and Kobilka Brian K. The molecular basis of G protein-coupled receptor activation. Annu.Rev.Biochem. 2018; 87:897–919.

Zalewska Marta , Siara Monika and Sajewicz Waldemar. G protein-coupled receptors: Abnormalities in signal transmission, disease states and pharmacotherapy. Acta Poloniae Pharmaceutica , Drug Research, 2014; 71(2 ): 229-243.

McCudden C. R., Hains M. D., Simple R. J., Siderovski D. P. and Willard F. S. G-protein signalling: back to the future. Cell. Mol. Life Sci. 2005; 62: 551–577.

Newton Alexandra C., Bootman Martin D. and Scott John D. Second messengers. Cold Spring Harb. Perspect. Biol. 2016; 1-15.

Liebmann Claus and Böhmer Frank-D. Signal transduction pathways of G protein-coupled receptors and their cross-talk with receptor tyrosine kinases: lessons from bradykinin signalling. Current Medicinal Chemistry, 2000; 7: 911-943.

Yang Li-Kun, Hou Zhi-Shuai and Tao Ya-Xiong. Biased signalling in naturally occurring mutations of G protein-coupled receptors associated with diverse human diseases. Molecular Basis of Disease. 2021; 1867: 1-18.

Lin Mu-En, Herr Deron R.and Chun Jerold. Lysophosphatidic acid (LPA) receptors: signalling properties and disease relevance. Prostaglandins Other Lipid Mediat. 2010; 91(3-4): 130-138.

Morshed Syed A., Risheng Ma, Latif Rauf and Davies Terry F. Biased signalling by thyroid stimulating hormone receptor-specific antibodies determines thyrocyte survival in autoimmunity. Sci. Signal. 2018; 11(514): 1-24.

Laugwitz K.L., Allgeier A., Offermanns S., Spicher K., Van Sande J., Dumont J.E. et al. The human thyrotropin receptor: a heptahelical receptor capable of stimulating members of all four G protein families. Proc.Natl.Acad.Sci. 1996; 93(1): 116-120.

Schafer Allison E.and Blaxall Burns C. G protein coupled receptor-mediated transactivation of extracellular proteases. J Cardiovasc Pharmacol. 2017; 70(1): 10–15.

Tuteja Narendra. Signalling through G protein coupled receptors. Plant Signalling & Behaviour. 2009; 4(10): 942-947.

Wang Zhixiang. Transactivation of epidermal growth factor receptor by G protein-coupled receptors: recent progress, challenges and future research. Int.J.Mol.Sci. 2016; 17(1): 1-12.